Answers are grounded in this paper and cite their sources.
There are considerable preclinical and clinical data showing that cyclooxygenase-2 (COX-2) plays an important role in the pathogen-esis of non–small-cell lung cancers (NSCLC).1,2 COX-2 is one of two isoforms of COX that catalyzes the conversion of arachidonic acid to prostaglandin (PG) G2, which is then reduced to an unstable endoper-oxide intermediate, PGH2.
No takes yet. Share an insight, caveat, or question.
Csiki et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: